<DOC>
	<DOCNO>NCT02463747</DOCNO>
	<brief_summary>Neutropenic fever life threaten condition rare patient suffer hematologic disorder , paramount importance early effective treatment . In trial concentrate hospitalize patient hematologic malignancy develop neutropenic fever . In recent year , several study conduct examine possible change conventional empirical treatment , assume administration antibiotic prolonged infusion would allow great fT &gt; MIC lead well efficacy . These study carry different population limit information importance continuous infusion therapy patient hematologic disease neutropenic fever . Research goal : The main goal compare two group hematologic patient neutropenic fever , The first group receive antibiotic therapy extend infusion , second ( control ) group receive treatment fixed time .</brief_summary>
	<brief_title>Short v Prolonged Antibiotic Treatment Hospitalized Hemato-oncology Patients With Febrile Neutropenia</brief_title>
	<detailed_description>METHODS : Each patient hospitalize Department Bone Marrow Transplantation meet Inclusion criterion , offer participate study . If fever appear hospitalization empirical treatment neutropenia initiate performed accordance allocation patient study . Therapeutic success define combination several clinical parameter , include : decline Fever , recurrence fever improvement infection . METHODS : Study format - Prospective unblinded randomize trial . Neutropenic fever measurement set fold 38.3 ° C fever 38.0 ° C last hour . Neutropenia define absolute neutrophil count ( ANC ) less 500 cell / mm3 , expect fall value next 48 hour . Primary care would one three option : 1 . Tazocin : 4.5gr , TID , I.V . Or 2 . Fortum ( Ceftazidim ) : 2.0gr , TID , I.V . - penicillin-sensitive patient . Or 3 . Meropenem : 1.0gr , TID , I.V . - In case hypotension respond fluid resuscitation , consultation infectious disease unit - start empirical treatment Meropenem . Supplementation Vancomycin discretion treat physician . Antibiotic therapy replace , coordination Department Infectious Diseases follow case : 1 . The fever decrease 24 hour 2 . The patient hemodynamically stable developes organ failure 3 . Evolving sensitivity response ( allergy ) suspect response antibiotic patient treat . 4. sensitivity response receive laboratory culture Bacteriologist demand change antibiotic . Replacement antibiotic therapy define failure define primary endpoint . In case , continue treatment patient would accord BMT unit protocol treatment neutropenic fever .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . Patients able sign inform consent form 2 . Hospitalized patient one follow reason : Induction consolidation Acute Leukemia Patients Hospitalized Autologous BMT Patients Hospitalized Allogeneic BMT . 1 . Patients age 18 . 2 . Patients unable provide inform consent . 3 . Patients acute lymphatic leukemia hospitalize maintenance treatment 4 . Patients stay entire duration neutropenia house .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Neutropenic fever</keyword>
	<keyword>extend infusion</keyword>
	<keyword>beta-lactam</keyword>
	<keyword>empiric antibiotic treatment</keyword>
</DOC>